BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Ribo and Boehringer Ingelheim Collaborate on Liver Disease Treatments

More than 440 million people worldwide are estimated to live with NASH, an inflammatory liver disease that is caused by accumulation of fat in the liver. O...

January 04, 2024 | News

NeuroBo Pharma Seeks FDA Approval for Obesity Treatment Trial

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, anno...

January 02, 2024 | News

Recbio's REC610 Shingles Vaccine Shows Positive Interim Trial Results in the Philippines

Previously, the Company conducted a GSK Shingrix® active-controlled FIH clinical trial of REC610 in the Philippines. The Interim Analysis (IA) res...

December 29, 2023 | News

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...

December 29, 2023 | News

HeraNova Lifesciences Raises $13.5M in Seed Funding for Women's Health Solutions

Heranova Lifesciences Holding Ltd. ("Heranova") announced the successful completion of a USD 13.5 million seed and seed+ financing to devel...

December 29, 2023 | News

Biocytogen and CtM Bio Advance in Developing Multi-Specific T Cell Engager against WT1/HLA-A02

In just one year since the start of the collaboration, the companies have identified a WT1/HLA-A02-specific T cell engager (WT1xCD3x4-1BB tri-specific anti...

December 28, 2023 | News

Innovent and SanegeneBio Collaborate on siRNA Drug for Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 27, 2023 | News

Everest Medicines' Partner Calliditas Announces Nefecon® as Sole FDA-Approved Treatment for Slowing IgA Nephropathy Kidney Decline

The FDA approval is for adults with primary IgAN who are at risk for disease progression, irrespective of proteinuria levels. Nefecon® is now a...

December 21, 2023 | News

CellOrigin Treats First CAR-M Patient in China, Unveils Second-Gen CAR-M for Solid Tumors

"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...

December 21, 2023 | News

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

Roche's Navify Digital Solutions Earn High Ratings in KLAS Research

Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilita...

December 20, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

December 19, 2023 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Vertex Gets Positive CHMP Opinion for First CRISPR Gene Therapy, CASGEVY™, for Sickle Cell Disease

- If approved by the European Commission, patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thal...

December 15, 2023 | News

Stay Connected